Patients should be aware that: No licensed combination product exists in the UK Any combination use would be considered experimental and is not supported by current evidence Clinical decisions must be guided by a qualified healthcare professional with access to current trial data Clinical Evidence and Trial Data Available to UK Patients Retatrutide Phase 2 data showed approximately 24% mean body weight reduction at the highest dose over 48 weeks, but no published trial data exist for the specific cagrilintideretatrutide combination
Compounded medications are not themselves FDA-approved but are legal, regulated, and made to pharmaceutical standards for personalized patient use
Looking at the medical data of more than 73,000 older adults, the researchers who conducted the study concluded that participants who expended more energy on a regular basis through moderate-to-vigorous exercise had a 14%40% lower risk of dementia, anxiety, depression, stroke, and even sleep disorders, compared to more sedentary peers
Using Zepbound, an injectable GLP-1 that costs $450 each month, means Kathryn has not been able to afford to travel like she hoped in retirement